Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Science 37
About
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
- Culver City,California,United States
- 251 - 500
- http://science37.com
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $35M
- Industries
- Biotechnology,Clinical Trials,Health Care,Home Health Care
- Founded date
- Jan 1, 2014
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Stock Symbol
- nasdaq:SNCE
- Legal Name
- Science 37, Inc.
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 7, 2021 | Post-IPO Equity | $200M | 14 | — | — | Detail |
| Oct 7, 2021 | IPO | $235M | — | — | — | Detail |
| Aug 20, 2020 | Series Unknown | $40M | 10 |
Lux Capital
Pharmaceutical Product Development
|
— | Detail |
| Jan 3, 2019 | Series D | $35M | 6 |
Pharmaceutical Product Development
|
— | Detail |
| Apr 25, 2017 | Series C | $35M | 7 |
Glynn Capital Management
|
— | Detail |
Investors
Employee Profiles
